Amyloid Disease: Are the oligomeric toxic species a good target for therapeutics?
Listen now
Description
It is believed that in many amyloid diseases, including Alzheimer’s, the primary toxic species responsible for neurodegeneration are small oligomers of the causative protein, rather than the fibres that often define the disease. I have, therefore, isolated oligomers of our model protein Cystatin B and those of Amyloid β in order to further characterise them.
More Episodes
Society’s response to dementia must be multi-faceted and at the University of Sheffield we have an impressive track record contributing to this response. Building on this and thinking ahead we have currently a range of cutting-edge postgraduate research studies being undertaken across different...
Published 08/27/15
Economic evaluation of healthcare interventions follows the guideline produced by the National Institute for Health and Care Excellence (NICE). NICE recommends a Cost Utility Analysis (CUA) approach where outcomes are health effects on patients (and carers where relevant) expressed in terms of...
Published 08/18/15